HK
Hemalatha Kovuri
About Hemalatha Kovuri
Data last updated:
Hemalatha Kovuri is a Director at Welcron Biotech Private Limited (since 2016). The companies operate in Chemicals. Welcron Biotech Private Limited reported revenue of ₹56.5 Lakh (FY 2017). Earlier, Hemalatha Kovuri was a Director at Zowin Life Sciences Private Limited (2021–2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 14 Mar 2016 | 2016 | ₹56.5 Lakh (FY 2017) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Jun 2021 | 2021 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hemalatha Kovuri
| Name | DIN | Company | Designation |
|---|---|---|---|
| John Babu Rachakonda | 09125559 | Welcron Biotech Private Limited | Director |
| Nageswararao Danduboyina | 08431007 | Welcron Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemalatha Kovuri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemalatha Kovuri
Hemalatha Kovuri currently holds 1 directorship: Welcron Biotech Private Limited (Director, since 14 Mar 2016, revenue ₹56.5 Lakh (FY 2017)).
Hemalatha Kovuri was first appointed on 14 Mar 2016 as Director at Welcron Biotech Private Limited. The most recent appointment on record is 16 Jun 2021 at Zowin Life Sciences Private Limited.
Hemalatha Kovuri held 1 earlier board appointment: Zowin Life Sciences Private Limited (Director, 16 Jun 2021 to 08 Mar 2023).
The current boards of Hemalatha Kovuri's companies include John Babu Rachakonda (Welcron Biotech Private Limited), Nageswararao Danduboyina (Welcron Biotech Private Limited).